JPH11246393A - Powder for preparing sparingly soluble medicament into quickly soluble formulation and production of the powder - Google Patents

Powder for preparing sparingly soluble medicament into quickly soluble formulation and production of the powder

Info

Publication number
JPH11246393A
JPH11246393A JP4931998A JP4931998A JPH11246393A JP H11246393 A JPH11246393 A JP H11246393A JP 4931998 A JP4931998 A JP 4931998A JP 4931998 A JP4931998 A JP 4931998A JP H11246393 A JPH11246393 A JP H11246393A
Authority
JP
Japan
Prior art keywords
particles
powder
thickener
soluble drug
dispersant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4931998A
Other languages
Japanese (ja)
Other versions
JP4266404B2 (en
Inventor
Masahiko Narasaki
雅彦 楢崎
Noriaki Okamura
憲明 岡村
Takao Fujii
隆雄 藤井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP04931998A priority Critical patent/JP4266404B2/en
Publication of JPH11246393A publication Critical patent/JPH11246393A/en
Application granted granted Critical
Publication of JP4266404B2 publication Critical patent/JP4266404B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject powder having good solubility and useful as a gargle through dissolving itself in water, by coating the surface of particles comprising a sparingly soluble medicament and a thickening agent with a dispersant. SOLUTION: This powder is obtained by coating the surface of particles comprising (A) a sparingly soluble medicament [pref. allopurinol, 2-(3-cyano-4- isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid, salicylic acid, or aspirin] and (B) a thickening agent (pref. sodium polyacrylate, carboxymethylcellulose or the like) in the weight ratio A/B of pref. (1:20) to (1:2) with (C) a dispersant (pref. xylitol, sorbitol or the like) and pref. (D) a dissolving auxiliary (pref. polyvinylpyrrolidone or macrogol). It is preferable that the surface of the particles is filmily coated with a layer comprising the components C and D, or both the components C and D are made to adhere in particulate form to the surface of the above particles.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は水に溶解して含嗽剤
等として用いられる難溶性薬物の速溶性用時調製用粉剤
およびこの粉剤を製造する方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a powder for rapidly dissolving a poorly soluble drug to be used as a gargle when dissolved in water, and a method for producing the powder.

【0002】[0002]

【従来の技術】これまで、増粘剤等を含む難溶性薬物の
含嗽剤等の調製は増粘剤自身の分散性、溶解性の低さか
らその調製には多大な手間と時間がかかるものであっ
た。たとえば、増粘剤を含むアロプリノール含嗽剤の調
製では、増粘剤とアロプリノールを乳鉢で粉砕、混和し
これに少量の水を加えゲル状にした後、水を加え60℃
に加熱しながら3時間攪拌することが行われている。
(例えば、Vol.13,No.6,1997,PHA
RMTECH JAPAN 参照)このようにして製造
された含嗽剤は、通常細菌の繁殖などを防ぐために一回
に使い切れる用量に小分けして保存したり、防腐剤の添
加を行わなければならなかった。
2. Description of the Related Art Up to now, preparation of a gargle for a poorly soluble drug containing a thickener or the like requires a great deal of labor and time due to the low dispersibility and solubility of the thickener itself. Met. For example, in the preparation of an allopurinol gargle containing a thickener, the thickener and allopurinol are pulverized and mixed in a mortar, mixed with a small amount of water to form a gel.
While stirring for 3 hours.
(For example, Vol. 13, No. 6, 1997, PHA
The gargle produced in this way had to be stored in small doses that could be used at one time, or had to be added with a preservative in order to prevent the growth of bacteria and the like.

【0003】[0003]

【発明が解決しようとする課題】このようにたとえば、
増粘剤を含むアロプリノール含嗽剤の調製には、まず増
粘剤と主薬(アロプリノール)を乳鉢で粉砕、混和する
必要があり、また、これを溶解して液状の含嗽剤とする
ためにも、増粘剤と主薬との混和物に水を加え60℃で
加熱しながら3時間も攪拌する必要があるために、調製
に多くの時間と手間がかかるという問題があった。ま
た、調製の煩雑さから予め数日にわたって利用できる量
を調製しておくのが通常であるが、このような場合には
2〜3日で主薬が析出してくるため製剤として安定性が
維持できないという問題があった。
Thus, for example,
To prepare an allopurinol gargle containing a thickener, it is necessary to first grind and mix the thickener and the active ingredient (allopurinol) in a mortar, and to dissolve this into a liquid gargle, Since it is necessary to add water to the mixture of the thickener and the main agent and to stir for 3 hours while heating at 60 ° C., there is a problem that much time and labor are required for preparation. In addition, it is usual to prepare an amount that can be used over several days in advance due to the complexity of preparation, but in such a case, the stability of the preparation is maintained because the main drug precipitates out in a few days. There was a problem that it was not possible.

【0004】[0004]

【課題を解決するための手段】本発明は、難溶性薬物と
増粘剤からなる粒子の表面を分散剤で被覆することによ
って、良好な溶解性を示し使用時に容易に調製できる速
溶性用時調製用粉剤を提供し、上記の問題を解決したも
のである。また、本発明では、上記の問題を解決するた
めの手段として以下の態様も好適に採用される。
DISCLOSURE OF THE INVENTION The present invention is directed to a method for rapidly dissolving a particle comprising a poorly soluble drug and a thickener, which shows good solubility and can be easily prepared at the time of use by coating the surface of the particle with a dispersant. A powder for preparation is provided to solve the above problems. In the present invention, the following aspects are also suitably adopted as means for solving the above-mentioned problems.

【0005】(1)該粒子の表面を分散剤と溶解補助剤と
で被覆する。 (2)該粒子の表面を分散剤と溶解補助剤との混合物でフ
ィルム状にコーティングすることで被覆する。 (3)該粒子の表面に分散剤と溶解補助剤を粒子状に付着
させることで被覆する。 (4)該粒子に増粘剤として、ポリアクリル酸ナトリウ
ム、カルボキシメチルセルロース、ヒドロキシプロピル
メチルセルロース、ゼラチンおよびショ糖脂肪酸エステ
ルから選ばれた少なくとも一種を含有させる。 (5)該粒子表面の被覆部に分散剤として、キシリトー
ル、ソルビトールおよびD−マンニトールから選ばれた
少なくとも1種を含有させる。 (6)該粒子表面の被覆部に分散剤と共に溶解補助剤とし
て、ポリビニルピロリドン、D−マンニトールおよびマ
クロゴールから選ばれた少なくとも1種を含有させる。 (7)増粘剤と難溶性薬物との混合物をスプレーで造粒し
た後、得られた粒子(造粒物)の表面を分散剤で(また
は分散剤と溶解補助剤とで)被覆することにより、速溶
性用時調製用粉剤を製造する。 (8)増粘剤と難溶性薬物とを遠心力で密着させる方法で
造粒をした後、得られた粒子(造粒物)の表面を分散剤
で(または分散剤と溶解補助剤とで)被覆することによ
り、速溶性用時調製用粉剤を製造する。 (9)増粘剤と難溶性薬物とを溶媒に溶解させた溶液を濃
縮、乾固した後、粉砕することで粒子化し、得られた粒
子(粉末)の表面を分散剤で(または分散剤と溶解補助
剤とで)被覆することにより、速溶性用時調製用粉剤を
製造する。 (10)増粘剤と難溶性薬物とを溶媒に溶解させた溶液をス
プレードライし粒子化した後、得られた粒子(粉末)の
表面を分散剤で(または分散剤と溶解補助剤とで)被覆
することにより、速溶性用時調製用粉剤を製造する。
(1) The surface of the particles is coated with a dispersant and a solubilizing agent. (2) The surface of the particles is coated with a mixture of a dispersant and a solubilizer in a film form. (3) The particles are coated by adhering a dispersant and a solubilizing agent on the surface of the particles. (4) The particles contain at least one selected from the group consisting of sodium polyacrylate, carboxymethylcellulose, hydroxypropylmethylcellulose, gelatin and sucrose fatty acid ester as a thickener. (5) At least one selected from the group consisting of xylitol, sorbitol and D-mannitol is contained in the coating on the surface of the particles as a dispersant. (6) At least one selected from the group consisting of polyvinylpyrrolidone, D-mannitol and macrogol is contained as a dissolution aid together with a dispersant in the coating on the surface of the particles. (7) After granulating a mixture of a thickener and a poorly soluble drug by spraying, coating the surface of the obtained particles (granulated material) with a dispersant (or with a dispersant and a solubilizer). Thus, a powder for quick-dissolution preparation at the time of use is produced. (8) After granulation by a method in which a thickener and a poorly soluble drug are brought into close contact with each other by centrifugal force, the surface of the obtained particles (granulated material) is treated with a dispersant (or a dispersant and a dissolution aid). ) By coating, a powder for quick dissolving preparation is prepared. (9) A solution obtained by dissolving a thickener and a poorly soluble drug in a solvent is concentrated and dried, and then pulverized into particles, and the surface of the obtained particles (powder) is dispersed with a dispersant (or a dispersant). And a dissolution aid) to produce a powder for quick dissolving preparation. (10) After a solution obtained by dissolving a thickener and a poorly soluble drug in a solvent is spray-dried and granulated, the surface of the obtained particles (powder) is treated with a dispersant (or a dispersant and a dissolution aid). ) By coating, a powder for quick dissolving preparation is prepared.

【0006】[0006]

【発明の実施の形態】本発明の粉剤は、使用の都度水ま
たはその他の適当な液状媒体に速やかに容易に溶解して
良好な製剤となり、したがって予め溶解しておく必要の
ない用時調製用粉剤であって、難溶性薬物と例えばポリ
アクリル酸ナトリウム、カルボキシメチルセルロースな
どの増粘剤とを粒子状にし、該粒子の表面をキシリトー
ル、ソルビトールのうち少なくとも一種の分散剤で、好
ましくはこれらの分散剤とポリビニルピロリドン、マク
ロゴールなどの溶解補助剤とで、被覆したものである。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The powder of the present invention is readily dissolved in water or another suitable liquid medium each time it is used to give a good preparation, and therefore, it can be prepared for use at the time of preparation which does not need to be dissolved in advance. A powder, in which a sparingly soluble drug and a thickener such as sodium polyacrylate and carboxymethyl cellulose are made into particles, and the surface of the particles is made of at least one dispersant of xylitol and sorbitol; And a dissolution aid such as polyvinylpyrrolidone and macrogol.

【0007】本発明の難溶性薬物とは、増粘剤を含む溶
媒中で分散性が悪いため水面に浮いたりダマ状になるな
ど短時間で溶解もしくは均一に懸濁しないものであれば
特に限定されないが、例えばアロプリノール、2-(3-シ
アノ-4-イソブトキシフェニル)-4-メチル-5-チアゾール
カルボン酸、サリチル酸(o-ヒドロキシ安息香酸)、
アスピリン、アズレン、アズレンスルホン酸ナトリウム
炭酸水素ナトリウム、臭化ドミフェン、ポピドンヨー
ド、アムホテリシンB等があげられ、なかでもアロプリ
ノールが好ましい。
The poorly soluble drug of the present invention is not particularly limited as long as it does not dissolve or uniformly suspend in a short time, such as floating on the water surface or becoming lumpy because of poor dispersibility in a solvent containing a thickener. But not allopurinol, 2- (3-cyano-4-isobutoxyphenyl) -4-methyl-5-thiazolecarboxylic acid, salicylic acid (o-hydroxybenzoic acid),
Aspirin, azulene, sodium azulene sulfonate sodium hydrogencarbonate, domiphen bromide, popidone iodine, amphotericin B and the like are mentioned, and among them, allopurinol is preferable.

【0008】難溶性薬物と増粘剤とを粒子状にする方法
としては、例えば(a)攪拌転動流動層造粒法(粉体を
空気で流動させながら攪拌翼で攪拌しつつスプレーで結
合液をを噴霧して粒子化する方法)、(b)高速攪拌造粒
法(粉体を攪拌翼で高速で攪拌しながらスプレーで結合
液を噴霧して粒子化する方法また、結合液を噴霧しなく
ても攪拌するだけで造粒されることもある)、(c)流動
層造粒法(粉体を空気で流動させながらスプレーで結合
液を噴霧して粒子化する方法)、(d)スプレードライ法
(主薬と増粘剤を溶解した溶液を乾燥雰囲気中に噴射し
乾燥させて粒子状とする方法)、(e)乾式造粒法(粉体
をローラーで圧縮しペレット状にした後粉砕して粒子化
する方法)、(f)主薬を水、エタノール、あるいはエタ
ノール水溶液などの溶媒に溶解した溶液を濃縮、乾固、
粉砕する方法、あるいは(g)高速気流中衝撃法(気流
中で粉体同士を衝突させることにより粒子化する方法)
などが採用される。
[0008] As a method of forming the hardly soluble drug and the thickener into particles, for example, (a) agitated tumbling fluidized bed granulation method (spray bonding while stirring the powder with air while stirring with a stirring blade); (B) a high-speed stirring granulation method (a method of spraying a binder liquid with a spray while stirring the powder at a high speed with a stirring blade, and spraying the binder liquid) (Agitation may be performed without stirring), (c) Fluidized bed granulation (a method of spraying a binding liquid by spraying while powder is fluidized with air), (d) ) Spray dry method (a method in which a solution in which a main drug and a thickener are dissolved is sprayed into a dry atmosphere and dried to form particles), and (e) dry granulation method (powder is compressed into a pellet by a roller. (F) Method of pulverizing by post-grinding), (f) Dissolving the active ingredient in water, ethanol, or aqueous ethanol solution The solution dissolved in the medium is concentrated, dried,
Pulverization method or (g) high-speed airflow impact method (a method of forming particles by colliding powders in an airflow)
Is adopted.

【0009】粒子の形状や大きさは、上記の方法のいず
れを採用するかによって異なるが、例えば上記(a)、
(c)の方法では増粘剤の表面に難溶性薬物が付着して
いる粒子となる。一方、上記(b)の方法では増粘剤と難
溶性薬物が非常に密に結合している粒子となリ、上記
(d)、(f)の方法では、増粘剤と難溶性薬物が均一
な固まりとなった粒子となる。また、(e)の方法で
は、増粘剤と難溶性薬物が混在する細かいフレーク状と
なっている。
The shape and size of the particles differ depending on which of the above methods is employed.
In the method (c), the particles become particles having a poorly soluble drug attached to the surface of the thickener. On the other hand, in the above method (b), the thickener and the poorly soluble drug become particles that are very tightly bound, and in the above methods (d) and (f), the thickener and the poorly soluble drug are mixed. The resulting particles are uniformly agglomerated. Further, in the method (e), a fine flake is formed in which a thickener and a poorly soluble drug are mixed.

【0010】本発明では、上記のいずれの粒子でもよ
く、粒子の大きさも用時溶解性を損なわない限り任意に
選択できるが、一般に、平均粒径100〜1500μ
m、特に500〜1000μm、が好適である。この範
囲で平均粒径の小さいものは粉末状またはこれに近い形
状となるが、そのような粒子も本発明の目的を達成する
ことができる。
In the present invention, any of the above particles may be used, and the size of the particles can be arbitrarily selected as long as the solubility at the time of use is not impaired.
m, particularly preferably 500 to 1000 μm. In this range, particles having a small average particle diameter are in the form of a powder or a shape close thereto, and such particles can also achieve the object of the present invention.

【0011】本発明において、難溶性薬物と増粘剤との
割合は、一般に難溶性薬物/増粘剤の重量比にして、1
/20〜1/2の範囲が粒子形成が容易であるため適当
である。
In the present invention, the ratio of the poorly soluble drug to the thickener is generally expressed as 1 weight ratio of the poorly soluble drug to the thickener.
The range of / 20 to 1/2 is appropriate because the formation of particles is easy.

【0012】該粒子には必要に応じ難溶性薬物と増粘剤
の他に着色剤、分散剤などの適当な補助成分を含んでも
差し支えない。
The particles may contain, if necessary, suitable auxiliary components such as a coloring agent and a dispersing agent in addition to the poorly soluble drug and the thickener.

【0013】本発明では、該粒子がキシリトールおよび
ソルビトールなどの分散剤で(好ましくは分散剤と溶解
補助剤とで)被覆されていることを必須とするが、被覆
するには、例えば(1)該粒子を空気または不活性気体
流動させておき、これに分散剤を(好ましくは分散剤と
溶解補助剤とを)水、エタノールなどの溶媒に溶解させ
た溶液をスプレーして流動粒子の表面に分散剤(好まし
くは分散剤と溶解補助剤)からなるフィルム状被膜を形
成させる方法、(2)空気または不活性気体で流動させ
た粒子の表面に、水、エタノールなどをスプレーするこ
とにより粉体の付着性を高めておき、これに分散剤(あ
るいは分散剤と溶解補助剤)を粉体状で直接付着させる
方法が採用される。
In the present invention, it is essential that the particles are coated with a dispersing agent such as xylitol and sorbitol (preferably with a dispersing agent and a solubilizing agent). The particles are allowed to flow in air or an inert gas, and a solution in which a dispersant (preferably, a dispersant and a solubilizing agent) is dissolved in a solvent such as water or ethanol is sprayed onto the surface of the fluidized particles. A method of forming a film-like film composed of a dispersant (preferably, a dispersant and a solubilizing agent); (2) powder by spraying water, ethanol, or the like on the surface of the particles fluidized with air or an inert gas; A method is adopted in which the adhesion of the dispersant (or the dispersant and the solubilizing agent) is directly adhered to the powder in a powder form.

【0014】本発明では、粒子の全表面を分散剤(ある
いは分散剤と溶解補助剤)で完全に被覆する必要は無
く、粒子の表面に該分散剤が粉末状あるいはフィルム状
で部分的に被覆した状態であっても差し支えない。
In the present invention, it is not necessary to completely coat the entire surface of the particles with the dispersant (or the dispersant and the solubilizing agent), and the dispersant is partially coated in the form of a powder or a film on the surface of the particles. There is no problem even if it is done.

【0015】難溶性薬物と増粘剤からなる粒子に対する
分散剤の量は、重量比で1/2〜4倍が好ましい。ま
た、溶解補助剤の量は粒子重量の1/20〜1/2倍が
好ましい。
The amount of the dispersant relative to the particles comprising the poorly soluble drug and the thickener is preferably 1/2 to 4 times by weight. The amount of the solubilizer is preferably 1/20 to 1/2 times the weight of the particles.

【0016】すなわち、分散剤などで被覆した粒子から
なる本発明の粉剤は、難溶性薬物100重量部に対して
100〜2000重量部、好ましくは500〜1000
重量部の増粘剤と、0〜1300重量部、好ましくは5
00〜1000重量部の溶解補助剤を含むものが適当で
ある。
That is, the powder of the present invention comprising particles coated with a dispersant or the like is used in an amount of 100 to 2000 parts by weight, preferably 500 to 1000 parts by weight, per 100 parts by weight of the poorly soluble drug.
Parts by weight of a thickener and 0 to 1300 parts by weight, preferably 5 parts by weight.
Those containing 100 to 1000 parts by weight of a solubilizer are suitable.

【0017】以上のような本発明に係る粉剤は、使用時
に水に速やかに溶解するので、その都度水に溶解して調
製し使用される。溶解する際に用いられる水の量は粉剤
の重量の150〜300倍が好ましい。
The powder according to the present invention as described above rapidly dissolves in water at the time of use, so that it is prepared and used by dissolving in water each time. The amount of water used for dissolution is preferably 150 to 300 times the weight of the powder.

【0018】[0018]

【実施例】以下に本発明の実施例を説明するが本発明を
これらの実施例に限定するものではないことはいうまで
もない。なお、実施例中の「%」は特に断らない限リ、
重量%を意味する。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Embodiments of the present invention will be described below, but it goes without saying that the present invention is not limited to these embodiments. In addition, "%" in the examples is unless otherwise specified.
% By weight.

【0019】[実施例1]アロプリノールに対して10
00重量%のポリアクリル酸ナトリウム(増粘剤)と、
アロプリノールに対して3000重量%のキシリトール
(分散剤)を攪拌転動流動層造粒機で水を結合液として
室温の空気中にスプレーし、平均粒子径が1000μm
になるまで造粒した。この粒子を顕微鏡で観察するとア
ロプリノールとポリアクリル酸ナトリウムからなる粒子
の表面をキシリトールが被覆していることが確認され
た。この粒子を室温の水に溶解させて含嗽剤を調製した
ところ約8分で安定な含嗽剤が得られた。
[Example 1] 10
00% by weight of sodium polyacrylate (thickener),
Xylitol (dispersant) of 3000% by weight with respect to allopurinol is sprayed into air at room temperature with water as a binding liquid by a stirring tumbling fluidized bed granulator, and the average particle diameter is 1000 μm
Until granulated. Observation of these particles with a microscope confirmed that the surfaces of the particles composed of allopurinol and sodium polyacrylate were coated with xylitol. When these particles were dissolved in water at room temperature to prepare a gargle, a stable gargle was obtained in about 8 minutes.

【0020】[実施例2]アロプリノールに対して10
00重量%のポリアクリル酸ナトリウム(増粘剤)を高
速攪拌造粒機でアロプリノールとともに攪拌することに
より、アロプリノールをポリアクリル酸ナトリウムに密
着させた粒子とし、さらにアロプリノールに対して30
00重量%のソルビトール(分散剤)と、アロプリノー
ルに対して500重量%のD−マンニトール(溶解補助
剤)をアロプリノールとポリアクリル酸ナトリウムとか
らなる粒子と高速攪拌造粒機で水を結合液として室温の
空気中にスプレーし、平均粒子径が1000μmになる
まで造粒した。この粒子を顕微鏡で観察するとアロプリ
ノールとポリアクリル酸ナトリウムからなる粒子の表面
をキシリトールが被覆していることが確認された。この
粒子を室温の水に溶解させて含嗽剤を調製したところ約
8分で安定な含嗽剤が得られた。
Example 2 10 parts of allopurinol
By stirring 00% by weight of sodium polyacrylate (thickener) together with allopurinol in a high-speed stirring granulator, allopurinol was converted into particles adhered to sodium polyacrylate.
00% by weight of sorbitol (dispersant) and 500% by weight of D-mannitol (dissolution aid) with respect to allopurinol Particles composed of allopurinol and sodium polyacrylate and water as a binder liquid by a high-speed stirring granulator. It was sprayed into air at room temperature and granulated until the average particle diameter became 1000 μm. Observation of these particles with a microscope confirmed that the surfaces of the particles composed of allopurinol and sodium polyacrylate were coated with xylitol. When these particles were dissolved in water at room temperature to prepare a gargle, a stable gargle was obtained in about 8 minutes.

【0021】[実施例3]アスピリンに対して500重量
%のポリアクリル酸ナトリウム(増粘剤)と、アスピリ
ンに対して1500重量%のキシリトール(分散剤)を
攪拌転動流動層造粒機で水を結合液として室温の空気中
にスプレーし、平均粒子径が1000μmになるまで造
粒した。この粒子を顕微鏡で観察するとアスピリンとポ
リアクリル酸ナトリウムからなる粒子の表面をキシリト
ールが被覆していることが確認された。この粒子を室温
の水に溶解させて含嗽剤を調製したところ約7分で安定
な含嗽剤が得られた。
Example 3 500% by weight of sodium polyacrylate (thickener) based on aspirin and 1500% by weight of xylitol (dispersant) based on aspirin were stirred by a tumbling fluidized bed granulator. Water was sprayed into the air at room temperature as a binding liquid, and granulated until the average particle diameter became 1000 μm. Observation of these particles with a microscope confirmed that the surfaces of the particles composed of aspirin and sodium polyacrylate were coated with xylitol. The particles were dissolved in water at room temperature to prepare a gargle, and a stable gargle was obtained in about 7 minutes.

【0022】[比較例]アロプリノールと、アロプリノ
ールに対して1000重量%のポリアクリル酸ナトリウ
ム(増粘剤)とを乳鉢で混和し、少量の滅菌精製水を加
えてゲル状にした後、60℃で3時間強制攪拌を行い溶
解し、次にオートクレーブで滅菌した。このすべての工
程を行うのにほぼ8時間かかった。
Comparative Example Allopurinol and 1000% by weight of sodium polyacrylate (thickener) based on allopurinol were mixed in a mortar, and a small amount of sterilized purified water was added to form a gel. For 3 hours to dissolve, and then sterilized in an autoclave. It took almost 8 hours to perform all of these steps.

【0023】[0023]

【発明の効果】本発明によれば、従来、増粘剤の溶解性
の悪さと凝集性から調製に時間と手間のかかった、たと
えばアロプリノール含嗽剤等の難溶性薬物の用時調製製
剤が、短時間で手間をかけずに調製することが可能とな
る。したがって、必要なときに本発明の粉剤を用いてす
ぐに製剤を調製して使用できるため、従来のアロプリノ
ール含嗽剤のような菌の増殖、主薬の析出などの心配が
ない。また、調製方法が簡便なため患者自身による調
製、携帯も可能である。
According to the present invention, conventionally, a time-consuming and time-consuming preparation due to poor solubility and cohesion of a thickener, for example, a preparation at the time of use of a poorly soluble drug such as allopurinol gargle, The preparation can be performed in a short time without any trouble. Therefore, since the preparation can be prepared and used immediately by using the powder of the present invention when necessary, there is no need to worry about the proliferation of bacteria and precipitation of the main drug as in the conventional allopurinol gargle. In addition, since the preparation method is simple, preparation and carrying by the patient himself are possible.

Claims (19)

【特許請求の範囲】[Claims] 【請求項1】 難溶性薬物と増粘剤からなる粒子の表面
を分散剤で被覆したことを特徴とする速溶性用時調製用
粉剤。
1. A fast-dissolving powder for use at the time of fast-dissolving, wherein the surface of particles comprising a poorly soluble drug and a thickener is coated with a dispersant.
【請求項2】 該粒子の表面を分散剤と溶解補助剤とで
被覆したことを特徴とする請求項1に記載の速溶性用時
調製用粉剤。
2. The powder according to claim 1, wherein the surface of the particles is coated with a dispersant and a solubilizing agent.
【請求項3】 該粒子の表面を分散剤と溶解補助剤とを
含む層でフィルム状にコーティングしたことを特徴とす
る請求項2に記載の速溶性用時調製用粉剤。
3. The powder according to claim 2, wherein the surface of the particles is coated with a layer containing a dispersant and a solubilizing agent in a film form.
【請求項4】 該粒子の表面に分散剤と溶解補助剤とを
粒子状に付着させたことを特徴とする請求項2に記載の
速溶性用時調製用粉剤。
4. The powder according to claim 2, wherein a dispersant and a solubilizing agent are attached to the surface of the particles in the form of particles.
【請求項5】 増粘剤として、ポリアクリル酸ナトリウ
ム、カルボキシメチルセルロース、ヒドロキシプロピル
メチルセルロース、ゼラチンおよびショ糖脂肪酸エステ
ルから選ばれた少なくとも一種を含有することを特徴と
する請求項1〜4のいずれか一項に記載の速溶性用時調
製用粉剤。
5. The method according to claim 1, wherein the thickener comprises at least one selected from sodium polyacrylate, carboxymethylcellulose, hydroxypropylmethylcellulose, gelatin and sucrose fatty acid ester. The powder for quick-dissolution preparation according to claim 1.
【請求項6】 分散剤として、キシリトール、ソルビト
ールおよびD−マンニトールから選ばれた少なくとも1
種を含有することを特徴とする請求項1〜4のいずれか
一項に記載の速溶性用時調製用粉剤。
6. A dispersant comprising at least one selected from xylitol, sorbitol and D-mannitol.
The powder according to any one of claims 1 to 4, which comprises a seed.
【請求項7】 溶解補助剤として、ポリビニルピロリド
ンおよびマクロゴールから選ばれた少なくとも1種を含
有することを特徴とする請求項2〜4のいずれか一項に
記載の速溶性用時調製用粉剤。
7. The powder according to claim 2, which contains at least one selected from polyvinylpyrrolidone and macrogol as a solubilizing agent. .
【請求項8】 難溶性薬物として、アロプリノール、2-
(3-シアノ-4-イソブトキシフェニル)-4-メチル-5-チア
ゾールカルボン酸、サリチル酸(o-ヒドロキシ安息香
酸)、アスピリンから選ばれた少なくとも1種を含有す
ることを特徴とする請求項1〜4のいずれか一項に記載
の速溶性用時調製用粉剤。
8. The sparingly soluble drug includes allopurinol and 2-
2. The composition according to claim 1, further comprising at least one selected from (3-cyano-4-isobutoxyphenyl) -4-methyl-5-thiazolecarboxylic acid, salicylic acid (o-hydroxybenzoic acid) and aspirin. The powder for quick-dissolution preparation according to any one of Items 1 to 4.
【請求項9】 難溶性薬物と増粘剤とを含む粒子を形成
した後、得られた粒子の表面の少なくとも一部を、分散
剤及び/又は溶解補助剤で被覆することを特徴とする速
溶性用時調製用粉剤の製造法。
9. Forming particles containing a poorly soluble drug and a thickener, and then coating at least a part of the surface of the obtained particles with a dispersant and / or a solubilizing agent. A method for producing a powder for sexual preparation.
【請求項10】 難溶性薬物と増粘剤との混合物を空気
中で流動させながら攪拌翼で攪拌しつつスプレーで結合
液を噴霧することにより粒子状とすることを特徴とする
請求項9に記載の速溶性用時調製用粉剤の製造法。
10. The method according to claim 9, wherein the mixture of the poorly soluble drug and the thickener is formed into particles by spraying the binding liquid with a spray while stirring with a stirring blade while flowing in air. The method for producing a powder for quick dissolution preparation according to the above.
【請求項11】 難溶性薬物と増粘剤との混合物を遠心
力で難溶性薬物と増粘剤を密着させて造粒することによ
り粒子状とすることを特徴とする請求項9に記載の速溶
性用時調製用粉剤の製造法。
11. The mixture according to claim 9, wherein the mixture of the poorly soluble drug and the thickener is granulated by bringing the poorly soluble drug and the thickener into close contact with each other by centrifugal force and granulating the mixture. A method for producing a powder for quick dissolving preparation.
【請求項12】 難溶性薬物と増粘剤との混合物を空気
で流動させながらスプレーで結合液を噴霧して粒子状と
することを特徴とする請求項9に記載の速溶性用時調製
粉剤の製造法。
12. The powdery preparation for quick dissolution according to claim 9, wherein the mixture of the poorly soluble drug and the thickener is sprayed while spraying the binding liquid into particles while flowing the mixture with air. Manufacturing method.
【請求項13】 難溶性薬物と増粘剤とを溶媒に溶解さ
せた溶液を、スプレードライすることによリ粒子状とす
ることを特徴とする請求項9に記載の速溶性用時調製用
粉剤の製造法。
13. The preparation according to claim 9, wherein the solution obtained by dissolving the poorly soluble drug and the thickener in a solvent is re-particled by spray drying. Powder manufacturing method.
【請求項14】 難溶性薬物と増粘剤との混合物をロー
ラーで圧縮しペレット状にした後粉砕することにより粒
子状とすることを特徴とする請求項9に記載の速溶性用
時調製用粉剤の製造法。
14. The preparation according to claim 9, wherein the mixture of the poorly soluble drug and the thickener is compressed by a roller into pellets and then crushed into particles. Powder manufacturing method.
【請求項15】 難溶性薬物と増粘剤とを溶媒に溶解さ
せた溶液を濃縮、乾固した後、粉砕することにより粒子
状とすることを特徴とする請求項9に記載の速溶性用時
調製用粉剤の製造法。
15. The quick-dissolving solution according to claim 9, wherein a solution obtained by dissolving the poorly-soluble drug and the thickener in a solvent is concentrated, dried, and then pulverized into particles. Production method of powder for preparation.
【請求項16】 難溶性薬物と増粘剤の混合物を、空気
または不活性気体の気流と回転版によって衝突させるこ
とにより粒子状とすることを特徴とする請求項9に記載
の速溶性用時調製用粉剤の製造法。
16. The method according to claim 9, wherein the mixture of the poorly soluble drug and the thickener is made into particles by colliding the mixture with air or an inert gas stream by a rotary plate. Manufacturing method of powder for preparation.
【請求項17】 難溶性薬物と増粘剤とからなる粒子
に、分散剤を含む溶液をスプレーして粒子表面を被覆す
ることを特徴とする請求項9に記載の速溶性用時調製用
粉剤の製造法。
17. The powder according to claim 9, wherein the surface of the particles comprising the sparingly soluble drug and the thickener is sprayed with a solution containing a dispersant to coat the surface of the particles. Manufacturing method.
【請求項18】 難溶性薬物と増粘剤とからなる粒子を
流動させ、それに分散剤を含む粉体を付着させることを
特徴とする請求項9に記載の速溶性用時調製用粉剤の製
造法。
18. The method according to claim 9, wherein particles comprising a poorly soluble drug and a thickener are caused to flow, and a powder containing a dispersant is adhered to the particles. Law.
【請求項19】 含嗽剤であることを特徴とする請求項
1に記載の速溶性用時調製用粉剤。
19. The powder according to claim 1, which is a gargle.
JP04931998A 1998-03-02 1998-03-02 Powder for preparation of quick-dissolving poorly soluble drugs and its production method Expired - Fee Related JP4266404B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP04931998A JP4266404B2 (en) 1998-03-02 1998-03-02 Powder for preparation of quick-dissolving poorly soluble drugs and its production method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP04931998A JP4266404B2 (en) 1998-03-02 1998-03-02 Powder for preparation of quick-dissolving poorly soluble drugs and its production method

Publications (2)

Publication Number Publication Date
JPH11246393A true JPH11246393A (en) 1999-09-14
JP4266404B2 JP4266404B2 (en) 2009-05-20

Family

ID=12827661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP04931998A Expired - Fee Related JP4266404B2 (en) 1998-03-02 1998-03-02 Powder for preparation of quick-dissolving poorly soluble drugs and its production method

Country Status (1)

Country Link
JP (1) JP4266404B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008007496A (en) * 2005-12-28 2008-01-17 Zenyaku Kogyo Kk Method for producing preparation using stirring type granulator
US8128961B2 (en) * 2000-11-28 2012-03-06 Irina Alekseevna Komissarova Pharmaceutical composition, the use thereof and method for producing said composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128961B2 (en) * 2000-11-28 2012-03-06 Irina Alekseevna Komissarova Pharmaceutical composition, the use thereof and method for producing said composition
JP2008007496A (en) * 2005-12-28 2008-01-17 Zenyaku Kogyo Kk Method for producing preparation using stirring type granulator

Also Published As

Publication number Publication date
JP4266404B2 (en) 2009-05-20

Similar Documents

Publication Publication Date Title
ES2334991T3 (en) FARMACO MICROPARTICLES.
JP3342868B2 (en) Product forming a thin film for coating a solid form, method for producing the same, and product coated with the product forming a thin film
US5324351A (en) Aqueous dispersions of zein and preparation thereof
TW575433B (en) Process for the manufacture of amorphous products by means of convection drying
JP3157158B2 (en) Wet powder film forming composition
CA1114744A (en) Pharmaceutical compositions containing urea
HU225964B1 (en) Moisture barrier film coating composition, method, and coated form
JP2538134B2 (en) Sustained release preparation and method for producing the same
JP2800242B2 (en) Manufacturing method of granules
JPH04234811A (en) Slow release of active chemical from bio-adhesive microcapsule
EP0834314B1 (en) Granules containing pranlukast, process for producing the granules, and method of lowering cohesiveness of pranlukast
Rodriguez et al. Preparation and characterization by morphological analysis of diclofenac/PEG 4000 granules obtained using three different techniques
WO1997003656A1 (en) Granular preparation and process for producing the same
US5372998A (en) Powdery material for preparing drug-coating solution
JP2958863B2 (en) Granulated product containing pranlukast, method for producing the same, and method for improving adhesion and cohesion of pranlukast
JPH11246393A (en) Powder for preparing sparingly soluble medicament into quickly soluble formulation and production of the powder
JPH06510532A (en) Method for manufacturing pharmaceutical compositions
CN102264243A (en) Process for preparing free-flowing powder containing deliquescent quaternary ammonium compound
JPH0240301A (en) Agricultural and horticultural granular wettable powder and production thereof
JP2006517929A (en) Method for producing agglomerates using melt agglomeration
JP3372242B2 (en) Sustained release particulate preparation and method for producing the same
JPH02223537A (en) Method for isolation of ibuprofen for direct making of tablets
JPS63112519A (en) Production of nifedipine preparation
JP2000504309A (en) Pharmaceutical granules
JPH0661458B2 (en) Composition having delayed reactivity or solubility with water or aqueous acid / alkali solution and method for producing the same

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040820

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040820

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080422

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080623

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080909

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081110

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20081224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090127

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090217

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120227

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120227

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130227

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130227

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140227

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees